Thalidomide-resistant HIV-associated aphthae successfully treated with granulocyte colony-stimulating factor.

Manders, S M; Kostman, J R; Mendez, L; Russin, V L · J Am Acad Dermatol · 1995

case_report · Level V

Where this comes from

Abstract

Thalidomide has been advocated as the treatment of choice for recalcitrant aphthae. We describe the case of patient with HIV infection and extensive aphthae whose condition failed to respond to corticosteroids, cyclosporine, and thalidomide. The patient's course was complicated by colonic aphthae. Rapid and sustained resolution was achieved through treatment with granulocyte colony-stimulating factor, a previously unreported therapeutic option.

Medical subject headings